+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis



Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis



Health Economics 9(2): 127-136



In a previous paper, it was argued that Societal Value measurement through person trade-off (PTO) elicitation offers a way to include the values of both general public and patients into cost-effectiveness analysis (CEA). It was said that patients' values could be used to estimate the effect that various health care dimensions have on health-related utility and that public values could be used to estimate the Societal Value of these changes in utility. However, this previous proposal still creates opportunities for the public to misvalue the benefit of health care interventions because of bias or misunderstanding about what the health-related utility really is of various illnesses or disabilities. A procedure that combines patient and public values into CEA to partially correct for this bias is suggested in this paper. In addition, it is pointed out that, although Societal Value measurement offers a role for distinctly public preferences in CEA, it still does not answer the question of whose utilities ought to be included in CEA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047391621

Download citation: RISBibTeXText

PMID: 10721014

DOI: 10.1002/(sici)1099-1050(200003)9:2<127::aid-hec500>3.0.co;2-y


Related references

A societal wealth justification of cost-effectiveness analysis. Jgim 10(4 Suppl ): 51, 1995

On the societal value of health care: what do we know about the person trade-off technique?. Health Economics 10(3): 233-243, 2001

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluation of the cost-effectiveness of coronary stenting: a societal perspective. American Heart Journal 137(5): S133-S137, 1999

Is the societal perspective in cost-effectiveness analysis useful for decision makers?. Joint Commission Journal on Quality Improvement 25(9): 447-454, 1999

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia. Plos One 8(11): E80639-E80639, 2014

Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations. Health Policy 43(1): 33-44, 1997

Societal Implications of Health Insurance Coverage for Medically Necessary Services in the U.S. Transgender Population: A Cost-Effectiveness Analysis. Journal of General Internal Medicine 31(4): 394-401, 2015

Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. Health Economics 17(7): 777-791, 2007

What's the trade-off between comparative effectiveness and cost-effectiveness analysis?. Expert Review of Pharmacoeconomics & Outcomes Research 8(5): 425-426, 2008

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 25(16): 3233-3239, 2007

Patient choice, cost, and survival of critically ill cancer patients: a societal dilemma. Journal of Cancer Research and Clinical Oncology 120(1-2): 3-4, 1993

Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost effectiveness analysis. Journal of Medical Economics (): 1-25, 2016

Societal values & modern medicine: how do we measure costs & benefits?. Journal of Community Health 4(2): 97-103, 1978

Cost-effectiveness analysis as a measure of value. Tecnologica: 1, 3-6, 9-10, 1995

A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data. Journal of Traumatic Stress 19(6): 787-797, 2007